Sclerotherapy sits in a gray zone most medspas underestimate: it's a needle-based medical procedure marketed as a cosmetic fix for spider and reticular veins, and most state boards still require a documented good faith exam before a nurse or injector can pick up a sclerosant syringe. This guide breaks down what a compliant exam actually looks like for vein-treatment providers in 2026 and which service models hold up under a board audit.
- Good faith exams for sclerotherapy need a documented vein history, not a generic medspa intake form.
- US Medical Directors pairs a physician-led exam with chart review every 90 days for vein clinics.
- Telehealth-only sign-offs skip the physical vessel assessment sclerotherapy requires beyond tiny spider veins.
- State supervision rules for sclerotherapy shift year to year; confirm your state’s 2026 requirements before scheduling.
- Annual exams without a chart review cadence leave the documentation gaps auditors flag first.
Why this matters
Boards don't treat sclerotherapy like a Botox touch-up. It carries real risk: deep vein thrombosis history, allergic reaction to the sclerosant, and vessel anatomy that varies patient to patient. A good faith exam that skips those questions isn't a good faith exam, it's a signature on a form.
In 2026, several states have tightened supervision language specifically around injectable and sclerosing agents, which pulls sclerotherapy into the same compliance conversation as neurotoxins and fillers. A medical director for sclerotherapy and vein clinics exists precisely because generic medspa oversight doesn't cover the vascular-specific questions a board expects on file.
Who this is for
This guide is for aesthetic nurses, nurse injectors, and estheticians who perform or plan to add sclerotherapy to a vein or medspa practice, plus the practice owners arranging supervision for them. If your intake form doesn't ask about clotting disorders, prior DVT, or pregnancy status, you're already exposed.
What to look for in a good faith exam for sclerotherapy
Vein-specific history, not a generic checklist
A sclerotherapy exam needs to ask about clotting disorders, prior DVT, hormone therapy, and pregnancy status before a single injection. A generic medspa form built for Botox doesn't capture any of that, and it's the first thing a board reviewer checks after an adverse event.
Physical assessment of the treatment area
Spider veins and larger reticular or varicose veins carry different risk profiles, and a physician needs to actually look at the legs, not just review a photo upload. Skipping this step is the single most common gap in weak good faith exam programs.
Documentation that ties the exam to the treatment plan
The exam file should note sclerosant type, planned session count, and any contraindications flagged during the visit. Chart review services exist to catch the cases where the exam and the treatment plan don't match, and that mismatch is exactly what gets flagged during an audit.
A renewal cadence that doesn't lapse
A good faith exam isn't a one-time event. Programs that renew annually without an interim chart review leave a documentation gap between visits, which is where most compliance findings originate.
Coverage that matches your full service menu
If your practice offers sclerotherapy alongside Botox, fillers, or laser hair removal, a program built only around good faith exams for medspas in general may not address the vein-specific questions above. Confirm the exam explicitly names sclerotherapy, not just "injectable services."
State alignment on supervision requirements
Supervision rules for sclerotherapy vary by state, and some states classify it under a stricter tier than neurotoxin injections. A program that hasn't been updated for your state's 2026 requirements is a liability, not a shortcut.
Top picks for sclerotherapy good faith exam programs
The safe pick: in-person, vein-focused physician exam.
A physician physically examines the treatment area, documents vessel type and prior clotting history, and signs off before the first session. Turnaround typically runs same-week, and the chart review cadence should sit at 90 days. Buy if you're running an active vein practice and need documentation that survives an audit.
The hybrid pick: telehealth intake with an in-person confirmation visit.
The patient completes history and screening remotely, then a physician confirms the physical findings in person before treatment begins. This shaves a few days off scheduling without skipping the physical exam. Consider it if your practice books patients on tight timelines and can still guarantee the in-person step happens. The best good faith exam providers for aesthetic nurses generally structure their hybrid model this way rather than skipping the physical step entirely.
The bundle pick: multi-modality good faith exam covering sclerotherapy plus injectables.
One exam visit covers sclerotherapy, Botox, and filler oversight under a single physician relationship, with quarterly chart review across all three service lines. Buy if sclerotherapy is one of several services on your menu and you want one compliance relationship instead of three. Nurse injectors managing a broad menu often start here because it consolidates paperwork; see how good faith exams for nurse injectors get structured when multiple treatment types are involved.
The wildcard: telehealth-only sign-off with no physical exam.
The entire exam happens over video, with no physician ever examining the legs in person. Turnaround is fast, often under 24 hours, but there's no physical vessel assessment on file. Skip it for anything beyond the smallest spider vein cases, and even then, expect a board reviewer to ask why no in-person visit occurred.
What to avoid
- Generic medspa compliance bundles that don't name sclerotherapy. If the exam paperwork only references "cosmetic injectables" without listing sclerosant type or vein classification, it won't hold up if a patient has a reaction.
- Annual-only programs with no interim chart review. A single exam per year looks compliant on paper until an incident happens between visits and there's nothing documented in between.
- Discount chart-review mills that batch-process files without reading them. A rubber-stamp review defeats the purpose of the good faith exam entirely and creates a false sense of coverage.
Verdict comparison
| Program type | Physical exam | Turnaround | Chart review cadence | Verdict |
|---|---|---|---|---|
| In-person, vein-focused | Yes | Same-week | 90 days | Buy |
| Hybrid telehealth + confirmation | Yes (confirmation visit) | 48-72 hours | 90 days | Consider |
| Multi-modality bundle | Yes | Same-week | Quarterly | Buy |
| Telehealth-only sign-off | No | Under 24 hours | None specified | Skip |
“If the exam file doesn’t include a vein assessment, it’s not a good faith exam, it’s a signature.”
Compliant paperwork does more than satisfy a board reviewer. Practices that keep a clean, consistent good faith exam record use that documentation as a trust signal in their own marketing, since patients researching vein treatment increasingly check for safety credentials before booking a consult, and pairing that trust signal with the right approach to attract more patients turns compliance into a growth lever instead of a cost center.
Set up sclerotherapy oversight now
Physician-led good faith exams and chart review for vein and medspa practices.
FAQ
What is a good faith exam for sclerotherapy?
It’s a physician-led evaluation that documents a patient’s vein condition, clotting history, and treatment plan before sclerotherapy begins. Most states require it as a precondition for nurses or estheticians to legally perform the procedure under physician oversight.
Who can perform a good faith exam for a sclerotherapy patient?
A licensed physician, or in some states a nurse practitioner or physician assistant acting under a collaborating physician agreement, performs the exam. The exact scope depends on your state’s supervision rules for injectable and sclerosing procedures in 2026.
How often does a sclerotherapy good faith exam need to be renewed?
Most compliant programs renew the exam annually, paired with chart review every 90 days between renewals. An annual-only cadence with no interim review leaves a documentation gap that boards flag during audits.
Can a telehealth good faith exam cover sclerotherapy?
A telehealth intake can gather history, but sclerotherapy generally needs a physical assessment of the treatment area at some point before the first session. Telehealth-only sign-offs without any in-person confirmation are a weak spot in an audit.
Is a good faith exam the same as informed consent?
No, they’re separate documents. The good faith exam establishes medical clearance and treatment appropriateness, while informed consent documents that the patient understands the risks and agreed to the procedure.
Does every state require a good faith exam before sclerotherapy?
Most states with physician supervision requirements for injectable procedures apply the same standard to sclerotherapy, but the exact language varies by state in 2026. Confirm your state’s current requirement before booking a session, since rules shift year to year.
How much does a good faith exam cost for sclerotherapy providers?
Cost depends on your state, provider volume, and whether the exam is bundled with broader medical director oversight. Practices running multiple service lines typically see better per-exam rates through a bundled program than through one-off exams.
What happens if a sclerotherapy provider skips the good faith exam?
Skipping it exposes the provider to practicing outside their scope and the practice to liability if a patient has a complication. It’s also the first document a state board requests during a complaint investigation.
One last thing
The detail that trips up most vein practices isn't the exam itself, it's the gap between exams. A physician who examines a patient in January and never sees the chart again until the annual renewal has no documented view into what happened at session four or five. Buy into a program with a quarterly chart review cadence, not just an annual exam, because that's the gap a board reviewer looks for first in 2026.
Related guides
